Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines

(2009) Alan Mackay et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

(2009) F. Andre et al.   CLINICAL CANCER RESEARCH

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

(2009) R. Natrajan et al.   CLINICAL CANCER RESEARCH

Pattern of metastatic spread in triple-negative breast cancer

(2008) Rebecca Dent et al.   BREAST CANCER RESEARCH AND TREATMENT

NOTCH3 Signaling Pathway Plays Crucial Roles in the Proliferation of ErbB2-Negative Human Breast Cancer Cells

(2008) N. Yamaguchi et al.   CANCER RESEARCH

Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer

(2008) I. Bernard-Pierrot et al.   CANCER RESEARCH

Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation

(2008) S. A. Byron et al.   CANCER RESEARCH

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

(2008) B. P. Schneider et al.   CLINICAL CANCER RESEARCH

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

(2008) Nicholas C Turner et al.   EMBO JOURNAL

Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia—A comparative study of four differently designed, high resolution microarray platforms

(2008) Rebeqa Gunnarsson et al.   GENES CHROMOSOMES & CANCER

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer

(2008) Wonshik Han et al.   GENES CHROMOSOMES & CANCER

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes

(2008) J S Reis-Filho et al.   HISTOPATHOLOGY

How basal are triple-negative breast cancers?

(2008) François Bertucci et al.   INTERNATIONAL JOURNAL OF CANCER

Refinement of breast cancer classification by molecular characterization of histological special types

(2008) B Weigelt et al.   JOURNAL OF PATHOLOGY

The genomic profile ofHER2-amplified breast cancers: the influence of ER status

(2008) C Marchiò et al.   JOURNAL OF PATHOLOGY

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

(2008) S.-M. Maira et al.   MOLECULAR CANCER THERAPEUTICS

ESR1 gene amplification in breast cancer: a common phenomenon?

(2008) Anne Vincent-Salomon et al.   NATURE GENETICS

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

(2008) Montserrat Garcia-Closas et al.   PLoS Genetics